TrialThe Lancet. Oncology2011

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.

Amrita Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.